Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125268203 | 12526820 | 3 | F | 20160420 | 20160801 | 20160705 | 20160815 | EXP | US-ACORDA-ACO_125474_2016 | ACORDA | 59.24 | YR | F | Y | 86.17000 | KG | 20160815 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 125268203 | 12526820 | 1 | PS | AMPYRA | DALFAMPRIDINE | 1 | Oral | 10 MG, Q 12 HRS | 0000079430 | 22250 | 10 | MG | TABLET | Q12H | |||||
| 125268203 | 12526820 | 2 | SS | AMPYRA | DALFAMPRIDINE | 1 | 22250 | TABLET | |||||||||||
| 125268203 | 12526820 | 3 | SS | DECADRON | DEXAMETHASONE | 1 | Oral | UNK, BID | U | 0 | BID | ||||||||
| 125268203 | 12526820 | 4 | C | TOVIAZ | FESOTERODINE FUMARATE | 1 | 8 MG, UNK | U | 0 | 8 | MG | ||||||||
| 125268203 | 12526820 | 5 | C | PRILOSEC | OMEPRAZOLE MAGNESIUM | 1 | 20 MG, UNK | U | 0 | 20 | MG | ||||||||
| 125268203 | 12526820 | 6 | C | LEXAPRO | ESCITALOPRAM OXALATE | 1 | Oral | 10 MG, QD | U | 0 | 10 | MG | QD | ||||||
| 125268203 | 12526820 | 7 | C | TYSABRI | NATALIZUMAB | 1 | Intravenous (not otherwise specified) | UNK, MONTHLY | U | 0 | /month |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 125268203 | 12526820 | 1 | Gait disturbance |
| 125268203 | 12526820 | 2 | Multiple sclerosis |
| 125268203 | 12526820 | 3 | Multiple sclerosis relapse |
| 125268203 | 12526820 | 4 | Product used for unknown indication |
| 125268203 | 12526820 | 5 | Product used for unknown indication |
| 125268203 | 12526820 | 6 | Depression |
| 125268203 | 12526820 | 7 | Multiple sclerosis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 125268203 | 12526820 | OT |
| 125268203 | 12526820 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 125268203 | 12526820 | Fall | |
| 125268203 | 12526820 | Fibula fracture | |
| 125268203 | 12526820 | Multiple sclerosis relapse | |
| 125268203 | 12526820 | Sepsis | |
| 125268203 | 12526820 | Staphylococcal infection | |
| 125268203 | 12526820 | Tibia fracture |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 125268203 | 12526820 | 3 | 201604 | 0 | ||
| 125268203 | 12526820 | 6 | 20151106 | 0 | ||
| 125268203 | 12526820 | 7 | 201502 | 0 |